Apple Inc. (NASDAQ: AAPL) was the big winner among only four that had appreciated. The following indicates commonly used metrics for tracking and comparing stocks.
Reviewing the stocks in order of lowest to highest P/E ratio (TTM):
It is interesting to note that only two of the eight have a below market P/E ratio, while only two are average. On the other hand, four are double the average and beyond, which leads me to believe the overall market consensus is that it is still very early in the game for these stocks and their futures are yet to be determined. The P/E ratios of the four are also the most volatile as are the stock prices.
TheStreet.com's Jim Cramer says FedEx exposed three market fictions with its news on Friday.
Sometimes you have to wonder why some stocks just don't stay down after bad news.
Take FedEx (NYSE: FDX) (Cramer's Take). Earlier this year, the stock shed about 10% of its value when it forecast worse-than-expected earnings, citing lower volumes and higher fuel costs. It then proceeded to rally 25% from that dismal forecast even as oil went up dramatically and business in the U.S., particularly retail business, got softer and softer!
Now we get pretty much a simple extension of what the company said last near the end of March, and people are acting surprised and furiously dumping the stock.
FedEx cuts to a couple abiding fictions in this market. The first is that all valuations are cheap, so it is OK to buy them. FedEx has long-term growth of 10% and sells at 14 times earnings, but I question both the growth and the multiple as being too high in a world where energy just won't quit. But that brings us to the second fiction: People have been buying this stock with the idea that oil just has to level off somewhere. Considering it didn't, how could anyone be surprised at this news? And the third fiction? The turn in the economy is right around the corner.
Welcome to the 60th installment of The Wal-Mart Weekly, a column dedicated to bringing you insight, wit, facts, results, opinions, and just a bit of everything else when it comes to a very hot topic these days: Wal-Mart.
In this Wal-Mart Weekly, I'll continue my column from last week and take a look at another of Wal-Mart Stores, Inc.'s (NYSE: WMT) annual shareholder meeting proposals.
Last year, I covered Wal-Mart's annual shareholder's meeting live from the show floor last year, where all 11 shareholder proposals were easily and soundly defeated. Will it be the same this year? We'll find out in about three weeks. Last week I covered something very pertinent to the season -- political contributions. This week, it'll be something more close to the heart of many individual -- and institutional -- shareholders: executive compensation.
The earnings season continues to roll on, and next week's results offer a peek at the state of fashion retailing, as a variety of companies -- from the discount to the upscale, from the hip to the pedestrian -- are scheduled to report earnings.
Analysts surveyed by Thomson Financial expect earnings growth, compared to the same period in the previous year, from Urban Outfitters (NASDAQ: URBN) to be 22.7% to 22 cents per share, from Wal-Mart Stores (NYSE: WMT) to be 9.3% to 75 cents per share, and from TJX Companies (NYSE: TJX) to be 7.5% to 40 cents per share.
Analysts expect earnings declines from the previous year from JC Penney (NYSE: JCP) by 52.9% to 49 cents per share, from Kohl's (NYSE: KSS) by 34.4% to 42 cents per share, and from Nordstrom (NYSE: JWN) by 18.3% to 49 cents per share.
In the case of Abercrombie & Fitch (NYSE: ANF), analysts expect earnings to remain flat, year over year, at 65 cents per share.
And then there's Macy's (NYSE: M), which is expected to swing to a loss of 2 cents per share, compared to a profit of 16 cents a year ago.
The sample size may be too small to define any significant trends, but the numbers do suggest that analysts expect profit declines to be deeper than profit growth, and that consumers may be more likely, given the current state of the economy, to buy clothes at Wal-Mart or TJ Maxx than at Nordstrom or Abercrombie.
The coming results will reveal if those expectations are correct.
Wal-Mart (NYSE:WMT) is scheduled to report Q1 on May 13. WMT June option implied volatility of 23 is below its 26-week average of 26 according to Track Data, suggesting decreasing price risk.
Gap (NYSE:GPS) is scheduled to report Q1 EPS on May 22. Buckingham Research says "We continue to rate the shares of GPS as Neutral due to valuation and lack of progress on a turnaround." GPS June option implied volatility of 41 is near its 26-week average, suggesting non-directional price risk.
Option Update is provided by Stock Specialist Paul Foster of theflyonthewall.com
Coinstar (NASDAQ: CSTR) offers North American and U.K. retailers a range of storefront service and entertainment devices. These include coin counters, kiddie rides, bulk vending machines, skill-crane games and point-of-sale terminals. The firm also provides self-service DVD movie rental/purchase kiosks and provides money transfer services, prepaid wireless products, stored value cards, payroll cards and prepaid debit cards. Coinstar products and services are distributed through more than 53,000 retail stores. Corporate clients include Wal-Mart (NYSE: WMT), Kroger (NYSE: KR) and Walgreen (NYSE: WAG).
The company surprised the Street last week, when it reported Q1 EPS of 18 cents and revenues of $190.5 million. Analysts had been expecting four cents and $182.7 million. Management also guided Q2 EPS to 8-15 cents (12 cent consensus), Q2 revenues to $200-$210 million ($202.19M consensus), FY08 EPS to 60-75 cents (57 cent consensus) and FY08 revenues to $850-$900 million ($829.83M consensus). DA Davidson subsequently upgraded the stock to "buy".
Is Target just trying to keep up, or does it see a benefit in matching drug price cuts by its larger competitor? In response to the price cuts, Target said that it "understands the challenges guests are facing in the current economic environment." It probably planned to make these price cuts as soon as Wal-Mart did and gain the same kind of free PR that comes with such a drastic price reduction in something that millions of Americans now depend on.
But Target does not position itself as the "low price" leader like Wal-Mart does. Its marketing is more upscale, and so is the appearance of its stores -- even while carrying much of the same merchandise. So why is Target matching these prescription drug price cuts? Is it trying to take customers from Wal-Mart? Of course -- the two are fierce competitors even though marketing and merchandise presentation strategies are what I'd consider to be worlds apart. Sometimes, price is everything.
Reuters reports that Wal-Mart Stores, Inc. (NYSE: WMT) posted better-than-expected revenue growth in the first quarter. As I suggested last month, this makes sense to me because Wal-Mart is the beneficiary of the recession diet.
The details suggest that Wal-Mart is becoming more popular than analysts expected thanks to its low prices and the squeezed consumer. Specifically, Wal-Mart sales rose 3.2% rise in April boosted by demand for basic items like groceries and medicine. Analysts, on average, were expecting same-store sales to rise 2.1%, according to Reuters Estimates; Wal-Mart had forecast a gain of 1% to 3%.
Why is this happening? People need food, shelter, medicine, and gasoline to drive back and forth from their jobs. And the price of all those items is rising. I estimate that the median family takes in $838 a week after tax. If that family fills up two tanks of gas a week -- that amounts to 40 gallons times $3.62 a gallon or $145 a week. That's 17% of the weekly budget compared to 15% a year ago when gasoline was $3.10 a gallon. Food prices have skyrocketed as well with rice prices tripling this year.
Unilever (NYSE: UL) is the world's second-largest maker of food and detergent, so you would expect the company to hurt with rising commodity prices. But Unilever has been proactive and has raised prices 4.8% in the quarter to offset its rising costs. In fact, the company said revenue will beat its forecast for the first time in six years on increased prices and sales of Dove soap, Hellmann's mayonnaise and Lipton tea. First-quarter net income climbed 33%, exceeding analysts' estimates.
As expected, April retail sales have so far indeed been strong, although there are some ares weakness is seen.
Costco (NASDAQ: COST) shares are up 1.2% in premarket trading after the warehouse club retailer said April same-store sales increased 8%, beating analysts' expectations of 6.1%.
Wal-Mart Stores Inc. (NYSE: WMT) shares are also higher in premarket trading, up 1.8%, after the world's largest retailer, said same-store sales climbed 3.2%, beating the 2.1% forecast by analysts. Staying with Wal-Mart for a moment, it said it plans to invest millions in Canada and open more supercenters.
The more luxurious items, though, such as lingerie sold at Limited Brands (NYSE: LTD) have seen a slowdown as the company said that April same-store sales fell 5%, falling short of the 2.3% sales decline analysts had anticipated.
These diversified funds have provided superior returns historically and are relatively conservative in their stock-picking and philosophy. Unlike with the specialty funds, you don't necessarily need to be a contrarian buying these. Following are some of those that made the list Morningstar recommends.
This post is part of our Battle of the Brands feature. Let us know which brand you prefer, and check out other Battle of the Brands posts.
In the suburban landscape littered with big-box retailers, it is no secret which are the favorites of the Friday morning housewives, the Saturday afternoon family shoppers. These are the stores so formidable that families can often be spotted pushing two carts to haul their weekly stock of everything from boxed wine and board books to T-shirts and toilet paper. And Wal-Mart Stores Inc. (NYSE: WMT) and Target Corp. (NYSE: TGT) are the very exemplification of our Battle of the Brands showdown: for most of you, it's either one or the other, never both. In the world of bargain retail megastores, loyalties run deep.
And naturally, both Wal-Mart and Target are forever trying to move in on each others' turf. While Target has always been known for its partnerships with cutting-edge fashion icons (regular shoppers often call it "Tar-jay," with a French accent, though the corporation is firmly rooted in the American Midwest), Wal-Mart has been known for tripping over its own fashion foot. Wal-Mart has emphasized its ability to deliver every single last thing to its customers (from banking to bebop to "green" coffee).
This year has marked a few nuances to the two companies' strategies. Target has been wooing upper-middle-income shoppers who are now looking for better values, with a rumored experiment with high-end cosmetics, a refinement of its furniture offerings, and a focus on labeling foods so consumers will feel more secure purchasing its fresh groceries.
The cognitive dissonance confronting people who hate Wal-Mart (NYSE: WMT) but lament the cost of prescription drugs is growing stronger.
In a press release on Monday, the retailer announced that "Beginning today, Wal-Mart, Neighborhood Market and Sam's Club pharmacies will fill prescriptions for up to 350 generic medications at $10 for a 90-day supply." Wal-Mart is also adding adding $9 generic prescriptions for up to a 30-day supplies for drugs treating osteoporosis, breast cancer, menopause and hormone deficiency, in addition to a new "$4 OTC offering," consisting of more than 1,000 products available without a prescription priced at $4 or less.
According to Wal-Mart, roughly "95 percent of the prescriptions written in the majority of therapeutic categories are included in the $4 Prescription Program." In the less than three years since it launched its cheap prescription drugs initiative, Wal-Mart estimated that it has saved consumers over $1 billion on health care.
But wait, there's more! At 7:26 PM EDT, Target (NYSE: TGT) responded with a press release stating that "As part of its ongoing commitment to provide exceptional value to guests and consistent with prior practices, Target will reduce prices on its prescription and over-the-counter drug offerings, remaining competitively priced with Wal*Mart."
Like most price wars, this one looks to turn out well for cash-strapped consumers.
But a word to the wise: part of the reason Wal-Mart and Target are doing this is that they want you to wander around and shop while you wait for your medication. So if you use a big-box store's pharmacy, bring a book or magazine and pull up a chair -- the savings will be nullified if you walk out of there with a $4 prescription and $30 worth of crap you don't need.
Avoid These Ugly, Risky Stocks For the moment, the market seems to have settled. Does that mean the worst is over? It's unclear. You should still be cautious. The key to investing during a crisis is making sure that the stocks you're buying truly are isolated from the blow-up. Avoid These Ugly, Risky Stocks - Motley Fool
10 Auto Brands in Trouble -- Which Auto Brands Should Go? Should Ford Motor dump Mercury and Volvo? What will happen with GMC, Hummer, Jaguar and Linconl?There are too many brands and not enough buyers. Many auto-industry insiders agree weak ones should go, but it's not that easy. Which Auto Brands Should Go? - BusinessWeek In Pictures: 10 Auto Brands in Trouble
Welcome to the 59th installment of The Wal-Mart Weekly, a column dedicated to bringing you insight, wit, facts, results, opinions, and just a bit of everything else when it comes to a very hot topic these days: Wal-Mart.
In this week's Wal-Mart Weekly, I'll begin a multi-part column that takes a look inside some of Wal-Mart Stores, Inc.'s (NYSE: WMT) annual shareholder meeting proposals. As many of you may know, Wal-Mart's annual shareholder's meeting happens in early June, about a month from now.
I covered it live from the show floor last year, where all 11 shareholder proposals were easily and soundly defeated. Nothing new here, as Wal-Mart's board has a habit of glossing past many proposals that would give its shareholders a glimpse into its internal operations.
So, let's start off by looking at a shareholder proposal that asks for more public visibility into Wal-Mart's political donations. This is a great question for the retailer, and one would think that if Wal-Mart has nothing to hide, it would open the transparency book to answer this proposal. We'll only know in a month when the meeting actually happens, but we'll consider what the retailer could do in this column. Visit this link to get a rundown on Wal-Mart's SEC Form 14A for its upcoming shareholder's meeting, and then join me after the break.
About a month ago I posted Serious Money: AAPL, EBAY, GE, GOOG, MSFT, TWX, WMT, YHOO -- one more look, covering the original Great Eight stocks we focused on at BloggingStocks. These were based on reader interest, which they do still generate today.
The earnings season continues to roll on, and next week's results offer a peek at the state of fashion retailing, as a variety of companies -- from the discount to the upscale, from the hip to the pedestrian -- are scheduled to report earnings.
.gif){kind=logo}
Wal-Mart
This post is part of our 
Irvine Robbins' taste for business success
Will broadcasters stick to a new 52-week model?
Oil supply to grow more than demand so why is gas at a record high?
